Yariv Houvras
Universidade do Sul de Santa Catarina
ORCID: 0000-0003-0751-3215Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial”.
Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more
Jacques A. Villefranc, Timothy M. Ullmann, Jessica W. Thiesmeyer, Viviana Anelli, Jun Yao +26 more
Gabriel D. Bossé, Isaac M. Oderberg, Sebastian Akle, Yariv Houvras, Paul J. Wrighton +13 more
Raúl Martinez-McFaline, Caitlin Gribbin, Paul J. Wrighton, Courtney A. Balgobin, Isabel S. Nelson +11 more
Alexander C. Jordan, Irineu Illa Bochaca, Allison Izsak, Farbod Darvishian, Yariv Houvras +3 more
Evisa Gjini, Sagar Chhangawala, Hao Fan, Shuning He, Changbin Jing +8 more